Becker's Healthcare April 16, 2024
In the first quarter of 2024, the U.S. hit a 23-year record after logging 323 active drug shortages. And among GoodRx’s list of the nation’s 20 most popular therapies, half are in shortage.
Here are the 10 shortages, according to data from the FDA and the American Society of Health-System Pharmacists:
Albuterol: Nephron Pharmaceuticals Corp. is releasing solutions of the inhalation medication as they become available, according to the FDA, which lists increased demand as the reason for the shortage. Cipla USA discontinued two solutions of the medicine used for asthma and chronic obstructive pulmonary disease, but 14 others are available in the U.S. market, according to the ASHP.
Amoxicillin: Since fall 2022, dozens of the antibiotic’s presentations have...
Today's Sponsors
Today's Sponsor